Ozempic

Generic For Semaglutide Injection

Starting From

$280.00$380.00

Ozempic® is a once-weekly injectable medication designed to support weight loss when combined with a healthy diet and regular exercise. Administered under the skin, its dosage can be adjusted based on individual tolerance and clinical response. Carefully follow the included instructions upon receiving the product.

Key Details About Ozempic® for Weight Loss:

  • Purpose: Off-label use to promote weight loss alongside diet and exercise.
  • Starting Dose: 0.25 mg injected once weekly for the first 4 weeks.
  • Dose Adjustments: Gradually increase to 0.5 mg weekly, with the option to further adjust up to a maximum of 2 mg weekly if needed, depending on tolerance.
  • Administration Timing: Inject at least 30 minutes before consuming your first meal, drink, or other medications.
  • Storage Requirements:
    • Refrigerate between 2°C and 8°C (36°F to 46°F).
    • Alternatively, store at room temperature (59°F to 86°F) for up to 56 days.
  • Supply: Each pen contains 4 doses, providing a 30-day supply.

Always use Ozempic® as directed and store it properly to maintain its effectiveness.

Side Effects

Ozempic®

Ozempic® is a medication used to assist with weight loss when combined with diet and exercise. Administered as a weekly subcutaneous injection, its dosage may be adjusted based on clinical response and tolerance. Carefully follow the package instructions upon receiving the product.

By clicking the “I Agree” button below, you certify under penalty of perjury that the following statements are true and correct and acknowledge that a medical provider will rely on the accuracy of your statements to determine whether a prescription is warranted and appropriate.

I agree that I:
  • am 18 years or older.
  • have not had a hypersensitivity reaction to Ozempic®, semaglutide, or any component of the formulation.
  • have taken and tolerated the previous dosing titration (if applicable).
  • do not have a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2).
  • do not have Type 1 diabetes or diabetic ketoacidosis (DKA).
  • understand that the use of Ozempic® for weight loss is not approved by the FDA and constitutes off-label use.
  • understand psychiatric effects, such as suicidal thoughts, have been reported with other medications for weight management.
  • have not had bariatric surgery.
  • understand this medication may slow gastric emptying, which can alter the absorption of other medications.
  • understand this medication has been associated with acute kidney injury, diabetic retinopathy, gallbladder disease, gastrointestinal side effects, and pancreatitis.
  • am not pregnant or breastfeeding.
  • do not have liver (hepatic) or kidney (renal) impairment.
  • understand this is not a comprehensive list of precautions, risks, side effects, or details about taking this medication.
  • understand drug interactions have not been reviewed against the other medications, supplements, or herbal products I may be taking unless also filled by Bitoke.
  • understand that Bitoke LLC does not provide medical care and that the providers who use Bitoke to deliver telehealth services (“Telehealth Providers”) are not a replacement for your primary healthcare provider.
  • understand that the Telehealth Providers cannot:
    1. monitor ongoing health or lab values for side effects or efficacy,
    2. observe how I (or my pet) tolerate any prescribed treatment, or
    3. determine if the prescribed treatment is working as intended. I assume any risks associated with this modality of care and waive any future claims against Bitoke and/or the Telehealth Providers.
  • understand that by using this site, I have established a patient-client-doctor relationship and that the Telehealth Providers are directing me to consult my primary healthcare provider soon after starting any treatment prescribed by the Telehealth Providers.
  • understand that this is a supplemental mode of care for my convenience, and the Telehealth Providers are not a replacement for in-person follow-up visits or interactions with my primary healthcare provider.